Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors

A serum-based DNA methylation assay provides accurate detection of glioma

(2021) Thais Sabedot et al.   NEURO-ONCOLOGY

DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features

(2021) Maritza S Mosella et al.   NEURO-ONCOLOGY

The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation

(2021) Davide Chicco et al.   BioData Mining

A DNA methylation-based liquid biopsy for triple-negative breast cancer

(2021) Katrina Cristall et al.   npj Precision Oncology

Pituitary-Tumor Endocrinopathies

(2020) Shlomo Melmed   NEW ENGLAND JOURNAL OF MEDICINE

Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes

(2020) Farshad Nassiri et al.   NATURE MEDICINE

Development and initial clinical correlation of a DNA methylation‐based blood test for prostate cancer

(2020) Jacob J. K. Carson et al.   PROSTATE

Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis

(2019) Zhongzheng Sun et al.   CLINICAL SCIENCE

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

(2019) Farshad Nassiri et al.   NEURO-ONCOLOGY

Identification of a pituitary ERα-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor

(2019) Vincent Pacini et al.   Epigenetics & Chromatin

Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma

(2019) Kaspars Megnis et al.   Frontiers in Endocrinology

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

(2019) Stephen J. Bagley et al.   CLINICAL CANCER RESEARCH

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

(2019) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Pangenomic Classification of Pituitary Neuroendocrine Tumors

(2019) Mario Neou et al.   CANCER CELL

Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel

(2019) Vera Constâncio et al.   Clinical Epigenetics

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

(2018) Katherine A. Hoadley et al.   CELL

The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes

(2018) Matthew P. Salomon et al.   CLINICAL CANCER RESEARCH

DNA methylation profiling in nonfunctioning pituitary adenomas

(2018) Paulina Kober et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Pan-cancer deconvolution of tumour composition using DNA methylation

(2018) Ankur Chakravarthy et al.   Nature Communications

ELMER v.2: an R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles

(2018) Tiago C Silva et al.   BIOINFORMATICS

Sensitive tumour detection and classification using plasma cell-free DNA methylomes

(2018) Shu Yi Shen et al.   NATURE

Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease

(2018) Joshua Moss et al.   Nature Communications

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

(2017) S L Asa et al.   ENDOCRINE-RELATED CANCER

Diagnosis and Treatment of Pituitary Adenomas

(2017) Mark E. Molitch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

DNA methylation markers for diagnosis and prognosis of common cancers

(2017) Xiaoke Hao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma

(2017) Binsheng Fu et al.   Biomed Research International

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

(2016) Michele Ceccarelli et al.   CELL

Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion

(2016) Ye Gu et al.   JOURNAL OF NEURO-ONCOLOGY

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

(2016) Sebastian Moran et al.   LANCET ONCOLOGY

The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma

(2016) Junmei Wang et al.   NEUROPATHOLOGY

Molecular Mechanisms Underlying Pituitary Pathogenesis

(2015) Melanie Sapochnik et al.   BIOCHEMICAL GENETICS

Sellar Masses: An Epidemiological Study

(2015) Khaled Al-Dahmani et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

(2015) Antonio Colaprico et al.   NUCLEIC ACIDS RESEARCH

A Pilot Genome-Scale Profiling of DNA Methylation in Sporadic Pituitary Macroadenomas: Association with Tumor Invasion and Histopathological Subtype

(2014) Chao Ling et al.   PLoS One

Causal analysis approaches in Ingenuity Pathway Analysis

(2013) Andreas Krämer et al.   BIOINFORMATICS

Low-level processing of Illumina Infinium DNA Methylation BeadArrays

(2013) Timothy J. Triche et al.   NUCLEIC ACIDS RESEARCH

Sensitivity × PPV is a recognized test called the clinical utility index (CUI+)

(2011) Alex J. Mitchell   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols